# Corrigendum: Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer

**Authors:** Weiwei Zeng, Yuning Luo, Dali Gan, Yaofeng Zhang, Huan Deng, Guohui Liu

PMC · DOI: 10.3389/fbioe.2025.1623425 · Frontiers in Bioengineering and Biotechnology · 2025-06-02

## Full-text entities

- **Diseases:** triple negative breast cancer (MESH:D064726)
- **Chemicals:** Doxorubicin (MESH:D004317)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12171397/full.md

---
Source: https://tomesphere.com/paper/PMC12171397